Further characterization of MycB treated DCs. (A) Flow cytometry experiment displaying relative mean fluorescence intensities (MFIs) for Cd11c (left) and MHC II (right) of DMSO- or 1 µM MycB–treated mature DCs, three biological replicates. (B) 7–Actinomycin D (7-AAD) life/dead stain flow cytometry histograms (left) and relative mean fluorescence intensities (right) of DMSO- or 1 µM MycB–treated mature DCs, three biological replicates.